Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAD001 in resectable soft tissue sarcomas
NCT01048723Phase 2Terminated
- Sponsor
- Moffitt Cancer Center
- Start
- Jan 2010
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in soft tissue sarcoma (STS), sponsored by Moffitt Cancer Center. Started Jan 2010; status: terminated.
02
Drugs
everolimus
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT01048723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01048723.